National Bank of Canada’s Kyntra Bio KYNB Stock Holding History

National Bank of Canada’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45K	Hold	193	–	–	﹤0.01%	2744
2026 Q1	$1.3K	Buy	+193	New	+$1.51K	﹤0.01%	2653
2025 Q4	–	Sell	-193	Closed	-$2.32K	–	2959
2025 Q3	$2.32K	Hold	193	–	–	﹤0.01%	2575
2025 Q2	$1.01K	Sell	193 -1	-0.5%	-$7	﹤0.01%	2697
2025 Q1	$1.48K	Hold	194	–	–	﹤0.01%	2534
2024 Q4	$2.57K	Hold	194	–	–	﹤0.01%	2554
2024 Q3	$1.94K	Hold	194	–	–	﹤0.01%	2361
2024 Q2	$3.74K	Hold	194	–	–	﹤0.01%	2321
2024 Q1	$5.62K	Hold	194	–	–	﹤0.01%	2288
2023 Q4	$4.03K	Hold	194	–	–	﹤0.01%	2345
2023 Q3	$3.94K	Buy	194 +126	+185%	+$4.95K	﹤0.01%	2402
2023 Q2	$4.58K	Hold	68	–	–	﹤0.01%	2356
2023 Q1	$31.6K	Hold	68	–	–	﹤0.01%	1846
2022 Q4	$27.1K	Hold	68	–	–	﹤0.01%	1932
2022 Q3	$22K	Sell	68 -26	-28%	-$8.37K	﹤0.01%	1984
2022 Q2	$25K	Hold	94	–	–	﹤0.01%	2002
2022 Q1	$28K	Hold	94	–	–	﹤0.01%	2059
2021 Q4	$33K	Buy	+94	New	+$29.3K	﹤0.01%	2006

Other funds holding KYNB

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

National Bank of Canada's KYNB Position: Q2 2026 in Review

National Bank of Canada held its Kyntra Bio (KYNB) position steady in Q2 2026 at 193 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2744.

National Bank of Canada first reported a position in KYNB in Q4 2021 and has held it in 18 quarters since. The position peaked at $33K in Q4 2021. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

National Bank of Canada held 193 shares of Kyntra Bio worth $1.45K as of Q2 2026.
National Bank of Canada left its Kyntra Bio share count unchanged in Q2 2026.
Kyntra Bio made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2744 holding.
National Bank of Canada first reported a position in Kyntra Bio in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's Kyntra Bio position peaked at $33K in Q4 2021.
27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.